ArteraAI vs Canary Speech
A side-by-side comparison built from both listings. Blank cells mean the company has not given that detail; we never guess.
ArteraAI compared with Canary Speech
| Detail | 
ArteraAI | 
Canary Speech |
|---|
| What it does | Personalized precision medicine powered by AI for cancer therapy
| Voice AI for objective health screening using vocal biomarkers
|
|---|
| Stage | Not given
| Established
|
|---|
| Founded | Not given
| Not given
|
|---|
| Based in | US
| US
|
|---|
| Pricing model | Contact for pricing
| Contact for pricing
|
|---|
| Pricing | Not given
| Not given
|
|---|
| Key features | - Analyzes digital pathology with no additional tissue staining required
- Rapid results within 1-2 days after specimen receipt
- Validated across diverse populations including African American and non-African American men
- FDA De Novo authorization for prostate cancer risk stratification
- Insurance coverage for Medicare and many commercial plans
- Provides 5 and 10-year distant metastasis risk for breast cancer
- Identifies breast cancer patients who benefit from chemotherapy
- Included in NCCN Clinical Practice Guidelines for Prostate Cancer
| - Voice biomarker analysis extracting acoustic, prosodic, and linguistic features
- Mood score assessment based on intonation, pitch variability, and speech rhythm
- Vocal stress score measuring physiological stress markers in voice
- Ambient listening for passive, non-intrusive voice monitoring
- 20-40 second audio analysis for rapid assessment
- HIPAA-compliant and HITRUST e1 certified platform
- API-first architecture for integration with healthcare systems
- Deep learning models trained on diverse demographic datasets
|
|---|
| What makes it different | - No additional tissue preparation needed, uses existing H&E slides
- Validated across multiple large randomized phase III clinical trials
- FDA De Novo clearance as Software as a Medical Device
- Financial assistance program to make tests affordable regardless of income
| - Patented voice biomarker technology enabling objective health screening in 20 seconds of speech
- Ambient listening capability, the industry's first for voice biomarker detection
- Early detection of conditions before observable symptoms appear
- Non-invasive audio-based analysis requiring no special equipment or procedures
- Enterprise-grade security and compliance with HIPAA, HITRUST, and ISO certifications
|
|---|
| Community votes | 0 | 0 |
|---|
| DR (Domain Rating by Ahrefs) | 57 ● no change since last check | 51 ● no change since last check |
|---|
| Trust Flow (Majestic) | 15 | 12 |
|---|
| Citation Flow (Majestic) | 27 | 20 |
|---|
| Referring domains (Majestic) | 285 | 282 |
|---|
5 details filled in for both companies.
More alternatives to ArteraAI More alternatives to Canary Speech